Bulletin
Investor Alert

Jan. 14, 2020, 1:04 a.m. EST

Topical Corticosteroids Market: Growth Dynamics by Key Players LEO, Almirall, S.A, Bausch Health, Cerecor, Inc., Sandoz International GmbH

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

Jan 14, 2020 (The Expresswire) -- Data Bridge Market Research adds "Global Topical Corticosteroids Market" new report to its research database. The report spread across 355 pages with multiple tables and figures in it.

Topical corticosteroids (steroids) is defined as a medications which is directly applied to the skin with intention to reduce irritation and inflammation, ; it is available in several different forms like ointments, gels, creams, lotions, mousses. They are available in four different potencies (strengths), known as mild, moderate, potent, and very potent

According to the CDC, in U.S 2 million people are infected with bacteria that are resistant to antibiotics, and at least 23,000 people die due to such infections. Increasing investment in research and development, act as a driver to the market.

Get a Sample Report Now @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-topical-corticosteroids-market

Global Topical Corticosteroids Market is expected to rise from its initial estimated value of USD 3154.01million in 2018 to an estimated value of USD 4877.24 million by 2026, registering a CAGR of 5.6% in the forecast period of 2019-2026. This rise in market value can be attributed to the increasing prevalence of chronic disease or condition.

Few of the major competitors currently working in the topical corticosteroids market are

GlaxoSmithKline plc. (UK),

Merck Sharp and Dohme Corp. (US),

LEO (Denmark),

Almirall,

S.A (Spain),

Bausch Health (Canada),

Cerecor, Inc.,

Sandoz International GmbH (Germany),

Pfizer Inc. (US),

Sanofi (France),

AstraZeneca (UK),

Almirall, LLC,

Godetia Healthcare,

Bayer AG,

McKesson Medical-Surgical Inc.,

Regeneron (US),

ALLERGAN (Ireland),

Galderma laboratories (Switzerland),

Novartis AG (Switzerland), and others.

Key Developments in the Market:

  • In April 2019, ViiV Healthcare announced that they got approval from US Food and Drug Administration (FDA) to Dovato, the first, once-daily, single-tablet, two-drug regimen for treatment.

  • In April 2019, GSK receives approval from U.S related to Benlysta for intravenous use in children with lupus aged five years and above.

Market Definition:

Topical corticosteroids (steroids) is defined as a medications which is directly applied to the skin with intention to reduce irritation and inflammation, ; it is available in several different forms like ointments, gels, creams, lotions, mousses. They are available in four different potencies (strengths), known as mild, moderate, potent, and very potent

According to the CDC, in U.S 2 million people are infected with bacteria that are resistant to antibiotics, and at least 23,000 people die due to such infections. Increasing investment in research and development, act as a driver to the market.

Market Drivers

  • The growing number of geriatric population, this act as a driver to the market.

  • Growth in demand of topical drug delivery drugs, this act as a driver to the market.

Market Restraints

  • Expiry of patent for drugs, this act as restraints to the market.

  • Weak reimbursement policies, this act as restraints to the market.

Order a Copy of This Research Report @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-topical-corticosteroids-market

Segmentation:

By Molecule Name

  • Fludroxycortide

  • Triamcinolone Acetonide

  • Fluocinolone Acetonide

  • Antiseptics

  • Betamethasone

  • Clobetasone Propionate

  • Clobetasone Butyrate

  • Halobetasone

  • Mometasone

  • Others

By Potency Class

  • Ultra High

  • High

  • Moderate

  • Mild

1 2
This Story has 0 Comments
Be the first to comment

Story Conversation

Commenting FAQs »
Link to MarketWatch's Slice.